To include your compound in the COVID-19 Resource Center, submit it here.

Fosrenol lanthanum carbonate: Phase III results; in EU and U.S. registration

Interim results from a 2-year U.S. Phase III study in 1,203 dialysis patients with

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE